Cargando…
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants
BACKGROUND: Pre-exposure prophylaxis (PrEP) is a novel HIV prevention method whereby HIV-negative individuals take the drugs tenofovir and emtricitabine to prevent HIV acquisition. Optimal adherence is critical for PrEP efficacy. Chemsex describes sexual activity under the influence of psychoactive...
Autores principales: | O'Halloran, Charlotte, Rice, Brian, White, Ellen, Desai, Monica, Dunn, David T, McCormack, Sheena, Sullivan, Ann K., White, David, McOwan, Alan, Gafos, Mitzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913514/ https://www.ncbi.nlm.nih.gov/pubmed/31739177 http://dx.doi.org/10.1016/j.drugpo.2019.10.007 |
Ejemplares similares
-
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial
por: White, Ellen, et al.
Publicado: (2019) -
The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour
por: Gafos, Mitzy, et al.
Publicado: (2018) -
Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study
por: Gafos, Mitzy, et al.
Publicado: (2017) -
Complex PrEP: the factors requiring consultant-led review of PrEP users
por: Tittle, Victoria, et al.
Publicado: (2022) -
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial
por: Miltz, Ada R., et al.
Publicado: (2019)